SIEMENS HEALTH ADR/050 Cash Flow Conversion Efficiency

Latest as of December 2025: 0.027x

SIEMENS HEALTH ADR/050 cash flow conversion efficiency. Based on the latest financial reports, SIEMENS HEALTH ADR/050 (SHL1) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€492.00 Million ≈ $575.20 Million USD) by net assets (€18.48 Billion ≈ $21.61 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SIEMENS HEALTH ADR/050 market capitalisation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of SIEMENS HEALTH ADR/050 (2022–2024)

Cash flow conversion efficiency of SIEMENS HEALTH ADR/050 from 2022 to 2024. This chart illustrates how SIEMENS HEALTH ADR/050's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for SIEMENS HEALTH ADR/050 for real-time trading data and today's change.

SIEMENS HEALTH ADR/050 Cash Flow Conversion Ratio Explained

SIEMENS HEALTH ADR/050 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

SIEMENS HEALTH ADR/050 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SIEMENS HEALTH ADR/050 ranked by their cash flow conversion efficiency. Review SIEMENS HEALTH ADR/050 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Waste Connections Inc
TO:WCN
0.090x
Polski Koncern Naftowy ORLEN SA
WAR:PKN
0.089x
Vistra Energy Corp
NYSE:VST
0.281x
Swedbank AB (publ)
ST:SWED-A
-0.020x
Samsung Biologics Co Ltd
KO:207940
0.075x
State Street Corp
NYSE:STT
-0.082x
Nike Inc
NYSE:NKE
0.031x
Hangzhou Hikvision Digital Technology Co Ltd
SHE:002415
0.089x

Annual Cash Flow Conversion Efficiency for SIEMENS HEALTH ADR/050 (2022–2024)

The table below shows the annual cash flow conversion efficiency of SIEMENS HEALTH ADR/050 from 2022 to 2024. Also see SIEMENS HEALTH ADR/050 balance sheet assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-09-30 €18.25 Billion
≈ $21.33 Billion
€2.83 Billion
≈ $3.30 Billion
0.155x +32.52%
2023-09-30 €18.13 Billion
≈ $21.20 Billion
€2.12 Billion
≈ $2.48 Billion
0.117x -7.35%
2022-09-30 €19.85 Billion
≈ $23.21 Billion
€2.50 Billion
≈ $2.93 Billion
0.126x --

About SIEMENS HEALTH ADR/050

F:SHL1 Germany Medical Devices
Market Cap
$46.68 Billion
€39.93 Billion EUR
Market Cap Rank
#573 Global
#117 in Germany
Share Price
€17.80
Change (1 day)
-4.81%
52-Week Range
€17.40 - €24.80
All Time High
€31.69
About

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more